StockData
Avenue Therapeutics, Inc. logo

Avenue Therapeutics, Inc. (ATXI) stock

ATXIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 4/30
$0.43+0.00 (0.00%)

Close on Oct 16, 2026Market cap $1.42MP/E –Yield –

Avenue Therapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Avenue Therapeutics's enterprise value was -$525.16K on Oct 16, 2026, against -$2.26M a year earlier. Over the last 5 years it ranged from -$4.32M to $23.09M, with a median of -$1.00M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 16, 2026-$525.16K–
2025Dec 31, 2025-$2.80M–
2024Dec 31, 2024-$346.68K-184.5%
2023Dec 29, 2023$410.24K-72.7%
2022Dec 30, 2022$1.50M-89.8%
2021Dec 31, 2021$14.66M-84.6%
2020Dec 31, 2020$95.32M-34.8%
2019Dec 31, 2019$146.21M+177.0%
2018Dec 31, 2018$52.77M+375.0%
2017Dec 29, 2017$11.11M–

More Avenue Therapeutics figures

See a number that looks wrong?